If you plan to update your membership, book an event or access APM Learning, APM Community or use other resources, please do this outside of these dates.
The 15 November Chartered Project Professional submission date is unaffected.
Thank you for your patience.
Alamy Images
Dolly the sheep
As the first animal to be cloned from an adult cell – previous attempts at cloning had used embryonic cells – Dolly shocked the world and opened up a whole range of exciting possibilities in medicine, including the development of personalised stem-cell treatments. The cloning process was the product of experiments led by Professor Sir Ian Wilmut at the Roslin Institute, with a team made up of scientists, embryologists, surgeons, vets and farm staff, and backed by biotech firm PPL Therapeutics. Since Dolly’s birth in 1996, pigs, deer, horses, cattle and monkeys have all been cloned using similar techniques, and – controversially – humans have had their genes edited using related CRISPR-Cas9 technology.
“Everyone, worldwide, knew that Dolly was important. And the full significance is far more profound than is generally appreciated” – Professor Sir Ian Wilmut